In its presentation at JPMorgan's Healthcare Conference in San Francisco, Illumina (ILMN -0.8%)...

|By:, SA News Editor

In its presentation at JPMorgan's Healthcare Conference in San Francisco, Illumina (ILMN -0.8%) says that preliminary Q4 revenue was $309M, beating Street expectations of $302M. EPS is tracking to the midpoint of range guidance. Street EPS estimates are for $0.42. (Presentation Webcast)